Net shares · 365d
-79.0K
0 buy · 79.0K sell
Net value · 365d
-$16.6M
$0 in · $16.6M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
62
0 buy · 79.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$655.3K
3.0K sh · $218.43 avg · 4 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$335.1K
1.7K sh · $202.84
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$693.6K
3.4K sh · $203.69 avg · 7 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$445.3K
2.2K sh · $204.10 avg · 2 lots
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$606.9K
3.0K sh · $202.30 avg · 3 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$186.8K
915 sh · $204.13
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$599.5K
3.0K sh · $199.85 avg · 3 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$1.1M
4.6K sh · $231.20 avg · 7 lots
Own -3%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$528.8K
2.2K sh · $238.97 avg · 2 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$5.5M
23.5K sh · $234.74 avg · 2 lots
Own -14%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$675.6K
3.0K sh · $228.95 avg · 2 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS
$1.1M
4.7K sh · $230.76
Own -4%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$714.5K
3.0K sh · $238.15 avg · 4 lots
Own -3%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$595.8K
3.0K sh · $198.60 avg · 3 lots
Own -3%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$423.2K
2.2K sh · $191.85 avg · 2 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$54.9K
292 sh · $187.95
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$480.0K
3.0K sh · $159.99 avg · 3 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$499.9K
3.0K sh · $166.62 avg · 3 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$136.0K
875 sh · $155.46 avg · 2 lots
Own -1%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$398.7K
3.0K sh · $132.88 avg · 3 lots
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$308.4K
2.2K sh · $139.81
Own -2%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$40.5K
291 sh · $139.29
Own -0%
-
NTRA Sell·S
PRESIDENT, CLINICALDIAGNOSTICS · 10b5-1
$500.3K
3.0K sh · $166.77 avg · 4 lots
Own -2%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 1, 2026 | NTRA | Sell S | 3.0K4 lots | $655.3K |
| May 26, 2026 | NTRA | Sell S | 1.7K | $335.1K |
| May 1, 2026 | NTRA | Sell S | 3.4K7 lots | $693.6K |
| Apr 27, 2026 | NTRA | Sell S | 2.2K2 lots | $445.3K |
| Apr 1, 2026 | NTRA | Sell S | 3.0K3 lots | $606.9K |
| Mar 10, 2026 | NTRA | Sell S | 915 | $186.8K |
| Mar 2, 2026 | NTRA | Sell S | 3.0K3 lots | $599.5K |
| Feb 3, 2026 | NTRA | Sell S | 4.6K7 lots | $1.1M |
| Jan 28, 2026 | NTRA | Sell S | 2.2K2 lots | $528.8K |
| Jan 21, 2026 | NTRA | Sell S | 23.5K2 lots | $5.5M |
| Jan 2, 2026 | NTRA | Sell S | 3.0K2 lots | $675.6K |
| Dec 12, 2025 | NTRA | Sell S | 4.7K | $1.1M |
| Dec 1, 2025 | NTRA | Sell S | 3.0K4 lots | $714.5K |
| Nov 3, 2025 | NTRA | Sell S | 3.0K3 lots | $595.8K |
| Oct 28, 2025 | NTRA | Sell S | 2.2K2 lots | $423.2K |
| Oct 21, 2025 | NTRA | Sell S | 292 | $54.9K |
| Oct 1, 2025 | NTRA | Sell S | 3.0K3 lots | $480.0K |
| Sep 2, 2025 | NTRA | Sell S | 3.0K3 lots | $499.9K |
| Aug 14, 2025 | NTRA | Sell S | 8752 lots | $136.0K |
| Aug 1, 2025 | NTRA | Sell S | 3.0K3 lots | $398.7K |
| Jul 28, 2025 | NTRA | Sell S | 2.2K | $308.4K |
| Jul 21, 2025 | NTRA | Sell S | 291 | $40.5K |
| Jul 1, 2025 | NTRA | Sell S | 3.0K4 lots | $500.3K |
Buy Sell Non-market (grant · exercise · gift)
About Moshkevich Solomon
This profile aggregates every SEC Form 4 insider transaction reported by Moshkevich Solomon across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.